Article
Genetically engineered T cells for cancer immunotherapy
19 Sept 2019
Abstract excerpt
T cells in the immune system protect the human body from infection by pathogens and clear mutant cells through specific recognition by T cell receptors (TCRs). Cancer immunotherapy, by relying on this basic recognition method, boosts the antitumor efficacy of T cells by unleashing the inhibition of immune checkpoints and expands adaptive immunity by facilitating the adoptive transfer of genetically engineered T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
